检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:贺学林[1] 陈以平[2] 邓跃毅[2] 张志刚[3] 郭慕依[3]
机构地区:[1]浙江大学医学院附属第一医院肾脏病中心,浙江杭州310003 [2]上海中医药大学附属龙华医院肾内科,上海200032 [3]复旦大学上海医学院病理教研室,上海200032
出 处:《上海中医药杂志》2003年第6期51-54,共4页Shanghai Journal of Traditional Chinese Medicine
基 金:上海市卫生局资助项目 (9940 7)
摘 要:为研究复方黄芪合剂 (主药 :黄芪、牛蒡子 )治疗DN的疗效与机理 ,4 5只大鼠以STZ诱导造成糖尿病模型 ,3d后分为 3组 ,B组给予复方黄芪合剂 ( 5g·kg- 1·d- 1)、C组给予洛汀新 ( 4mg·kg- 1·d- 1)药液灌胃 ,D组予等量生理盐水灌胃 (模型组 ) ,另一组大鼠为对照组 (A组 ) ,不作任何处理。 6周后比较各组大鼠的有关指标。结果 :B、C组大鼠的Ccr、Ualb、肾脏基质阳性面积比、Col Ⅳ、MMP 2、TIMP 2诸项指标均高于D组 ,其中GLU、HbAlc、Ccr三项指标B组优于C组。提示 :降低肾脏Col Ⅳ、MMP 2 /TIMP 2的表达 。To study the clinical efficacy and mechanism of 'Compound Huangqi Mixture'(CHM),45 rats were modeled with STZ into diabetic nephrosis and then randomized into three groups 3 days later. Group B was given 5g/kg·d -1 of CHM,group C was given 4mg/kg·d -1 of Lotensin and group D which was given equal amount of normal saline.Another 15 rats in group A with no treatment were used as control.The measurements were conducted 6 weeks later.Results:Ccr,Ualb,stromal positive area ratio,Col-Ⅳ,MMP-2 and TIMP-2 were higher in groups B and C than in group D,with better GLU,HbAlc and Ccr in group B than in group C.It is indicated that the Mixture may reduce Col-Ⅳ,MMP-2 and TIMP-2 to treat early diabetic nephosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222